Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Most patients experience a gradual return of appetite within 2 to 4 weeks after their final dose, though the speed varies based on genetics, lifestyle, and how long you remained on medication
A moderate increase in protein consumption can help preserve muscle mass during weight loss
NICE guidance recommends pharmaceutical GLP-1 receptor agonists at specific stages of diabetes treatment or for weight management with BMI 35 kg/m (or 32.5 kg/m for certain ethnic backgrounds) with weight-related comorbidities, typically within specialist services
Among the 18% of adults who report having ever used GLP-1 drugs, the vast majority (84%) say they have been diagnosed with at least one of the predominant conditions these drugs are prescribed to treat, including obesity or being overweight in the past five years (77%), or ever being diagnosed with diabetes (49%) or heart disease (21%)
The Middle East & Africa are expected to grow at a notable rate in the foreseeable future
US$ 28.99
US$ 22.99
US$ 21.48
US$ 26.39
US$ 23.66
